Literature DB >> 9591701

Immunohistochemical detection of MUC2 mucin core protein in ulcerative colitis.

Y Hinoda1, H Akashi, T Suwa, F Itoh, M Adachi, T Endo, M Satoh, P X Xing, K Imai.   

Abstract

MUC2 mucin is predominantly expressed in the colon and is considered to play an important role in the protection of that organ. Recent findings suggested that MUC2 protein levels are significantly decreased in active ulcerative colitis (UC). We therefore performed an immunohistochemical study to reveal if the expression of MUC2 protein is altered in UC. Seventy-nine biopsy tissue specimens from 31 UC patients, along with normal colon tissues, were immunostained with anti-MUC2 mucin core protein monoclonal antibody (MoAb) CCP58 (IgG1). UC tissue specimens were divided into two groups based on the histological severity of inflammation, i.e., 64 with active inflammation (grades 2-5) and 15 without (grade 1). In the former group, 52 out of 64 (81.3%) tissue specimens contained sections of glands with a few cells positive for MoAb CCP58. These glands were small and consisted of MUC2 negative-short cells and a few positive cells without apparent mucus formation, considered to be immature regenerative glands. In contrast, the staining pattern was almost the same as that of the normal colon and no immature glands were seen in the group without active inflammation. The sections of immature regenerative glands with a few MUC2-positive cells were exclusively found in the UC tissues with active inflammation, but not in those without it, suggesting that the expression of MUC2 protein may be decreased in active UC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9591701      PMCID: PMC6807796     

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  18 in total

1.  The value of rectal biopsy in the diagnosis of ulcerative colitis.

Authors:  S G MATTS
Journal:  Q J Med       Date:  1961-10

Review 2.  Functional biology of intestinal goblet cells.

Authors:  R D Specian; M G Oliver
Journal:  Am J Physiol       Date:  1991-02

3.  Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willebrand factor.

Authors:  J R Gum; J W Hicks; N W Toribara; B Siddiki; Y S Kim
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

4.  Second-generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer.

Authors:  P X Xing; J Prenzoska; G T Layton; P L Devine; I F McKenzie
Journal:  J Natl Cancer Inst       Date:  1992-05-06       Impact factor: 13.506

5.  Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer.

Authors:  S K Chang; A F Dohrman; C B Basbaum; S B Ho; T Tsuda; N W Toribara; J R Gum; Y S Kim
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

6.  Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types.

Authors:  M Blank; E Klussmann; S Krüger-Krasagakes; A Schmitt-Gräff; M Stolte; G Bornhoeft; H Stein; P X Xing; I F McKenzie; C P Verstijnen
Journal:  Int J Cancer       Date:  1994-11-01       Impact factor: 7.396

7.  Patterns of expression of lineage-specific markers during the in vitro-induced differentiation of HT29 colon carcinoma cells.

Authors:  A Velcich; L Palumbo; A Jarry; C Laboisse; J Racevskis; L Augenlicht
Journal:  Cell Growth Differ       Date:  1995-06

8.  Detection of the MUC2 apomucin tandem repeat with a mouse monoclonal antibody.

Authors:  G Gambús; C de Bolós; D Andreu; C Francí; G Egea; F X Real
Journal:  Gastroenterology       Date:  1993-01       Impact factor: 22.682

9.  Heterogeneity of mucin gene expression in normal and neoplastic tissues.

Authors:  S B Ho; G A Niehans; C Lyftogt; P S Yan; D L Cherwitz; E T Gum; R Dahiya; Y S Kim
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

10.  Expression of sulfated carbohydrate chains detected by monoclonal antibody 91.9H in human gastric cancer tissues.

Authors:  Y Ohe; Y Hinoda; T Irimura; K Imai; A Yachi
Journal:  Jpn J Cancer Res       Date:  1994-04
View more
  7 in total

1.  Cytokeratin 7/20 and mucin core protein expression in ulcerative colitis-associated colorectal neoplasms.

Authors:  Natsuko Tatsumi; Ryoji Kushima; Michael Vieth; Ken-Ichi Mukaisho; Rie Kakinoki; Hidetoshi Okabe; Franz Borchard; Manfred Stolte; Takeshi Okanoue; Takanori Hattori
Journal:  Virchows Arch       Date:  2006-04-12       Impact factor: 4.064

Review 2.  The Relationship between Mucins and Ulcerative Colitis: A Systematic Review.

Authors:  Esther Bankole; Emily Read; Michael A Curtis; Joana F Neves; James A Garnett
Journal:  J Clin Med       Date:  2021-04-30       Impact factor: 4.241

3.  Decreased expression of MUC2 due to a decrease in the expression of lectins and apoptotic defects in colitis patients.

Authors:  Agung A Wibowo; Bambang Pardjianto; Sutiman B Sumitro; Nia Kania; Kusworini Handono
Journal:  Biochem Biophys Rep       Date:  2019-06-05

4.  Goblet cells need some stress.

Authors:  Malin Ev Johansson; Gunnar C Hansson
Journal:  J Clin Invest       Date:  2022-09-01       Impact factor: 19.456

5.  Mucin dynamics in intestinal bacterial infection.

Authors:  Sara K Lindén; Timothy H J Florin; Michael A McGuckin
Journal:  PLoS One       Date:  2008-12-17       Impact factor: 3.240

6.  Mucosal barrier in ulcerative colitis and Crohn's disease.

Authors:  A E Dorofeyev; I V Vasilenko; O A Rassokhina; R B Kondratiuk
Journal:  Gastroenterol Res Pract       Date:  2013-05-07       Impact factor: 2.260

7.  Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis.

Authors:  Chad K Heazlewood; Matthew C Cook; Rajaraman Eri; Gareth R Price; Sharyn B Tauro; Douglas Taupin; David J Thornton; Chin Wen Png; Tanya L Crockford; Richard J Cornall; Rachel Adams; Masato Kato; Keats A Nelms; Nancy A Hong; Timothy H J Florin; Christopher C Goodnow; Michael A McGuckin
Journal:  PLoS Med       Date:  2008-03-04       Impact factor: 11.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.